# Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis

> **NCT03954158** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 81 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Crisaborole ointment 2%
- **DRUG:** Vehicle
- **DRUG:** Crisaborole ointment 2%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03954158
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-15
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954158, "Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03954158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*